未登录

M

Matthew R. Skelton

university of cincinnati

H指数:34

被引数:2,618

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

A mouse model of a patient derived P544L mutation in the Slc6a8 gene shows hypoactivity and cognitive deficits

IF2.6

2026-01-050

PRE

Dodecyl creatine ester, a promising treatment to deliver creatine to neurons, achieves pharmacology efficacy in creatine transporter deficiency

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY

IF5.9

2025-02-010

PRE

Impaired brain glucose metabolism as a biomarker for evaluation of dodecyl creatine ester in creatine transporter deficiency: Insights from patient brain-derived organoids and in vivo [18F]FDG PET imaging in a mouse model

NEUROBIOLOGY OF DISEASE

IF5.6

2024-11-011

OAAI

Deciphering neuronal deficit and protein profile changes in human brain organoids from patients with creatine transporter deficiency

从肌酸转运蛋白缺乏症患者中破译人脑类器官的神经元缺陷和蛋白质谱变化

IF0

2023-10-133

OA

Dodecyl creatine ester improves cognitive function and identifies key protein drivers including KIF1A and PLCB1 in a mouse model of creatine transporter deficiency

FRONTIERS IN MOLECULAR NEUROSCIENCE

IF3.8

2023-03-245

OAAI

Blueberry Supplementation in Midlife for Dementia Risk Reduction

IF5

2022-04-1326

OAAI

Creatine Transporter, Reduced in Colon Tissues From Patients With Inflammatory Bowel Diseases, Regulates Energy Balance in Intestinal Epithelial Cells, Epithelial Integrity, and Barrier Function

GASTROENTEROLOGY

IF25.1

2020-09-0159

OA

Intranasal carnosine attenuates transcriptomic alterations and improves mitochondrial function in the Thy1-aSyn mouse model of Parkinson's disease

MOLECULAR GENETICS AND METABOLISM

IF3.5

2018-11-0116

PREAI

Phosphodiesterase-1b (Pde1b) knockout mice are resistant to forced swim and tail suspension induced immobility and show upregulation of Pde10a

PSYCHOPHARMACOLOGY

IF3.3

2017-03-2321

OAAI

Creatine transporter deficiency leads to increased whole body and cellular metabolism

IF2.4

2016-07-1134

OAAI

Developmental stress and lead (Pb): Effects of maternal separation and/or Pb on corticosterone, monoamines, and blood Pb in rats

NEUROTOXICOLOGY

IF3.9

2016-05-0120

OAAI

Creatine transporter (SLC6A8) knockout mice display an increased capacity for in vitro creatine biosynthesis in skeletal muscle

FRONTIERS IN PHYSIOLOGY

IF3.4

2014-08-2628

OAAI

Prenatal immune challenge in rats: Altered responses to dopaminergic and glutamatergic agents, prepulse inhibition of acoustic startle, and reduced route-based learning as a function of maternal body weight gain after prenatal exposure to poly IC

IF1.6

2012-05-1562

OAAI

Neonatal Citalopram Treatment Inhibits the 5-HT Depleting Effects of MDMA Exposure in Rats

ACS CHEMICAL NEUROSCIENCE

IF3.9

2011-11-025

OA

In Utero and Lactational Exposure to PCBs in Mice: Adult Offspring Show Altered Learning and Memory Depending on Cyp1a2 and Ahr Genotypes

ENVIRONMENTAL HEALTH PERSPECTIVES

IF9.8

2011-09-0140

OAAI

Comparison of the elevated plus and elevated zero mazes in treated and untreated male Sprague-Dawley rats: Effects of anxiolytic and anxiogenic agents

PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR

IF2.5

2011-01-01172

OAAI

Neuronopathic Gaucher disease in the mouse: viable combined selective saposin C deficiency and mutant glucocerebrosidase (V394L) mice with glucosylsphingosine and glucosylceramide accumulation and progressive neurological deficits

HUMAN MOLECULAR GENETICS

IF3.2

2010-01-04121

OAAI

Specific saposin C deficiency: CNS impairment and acid β-glucosidase effects in the mouse

HUMAN MOLECULAR GENETICS

IF3.2

2009-12-1627

OAAI

Comparison of the developmental effects of 5-methoxy-N,N-diisopropyltryptamine (Foxy) to (±)-3,4-methylenedioxymethamphetamine (ecstasy) in rats

PSYCHOPHARMACOLOGY

IF3.3

2009-02-0622

OA

Neurological deficits and glycosphingolipid accumulation in saposin B deficient mice

HUMAN MOLECULAR GENETICS

IF3.2

2008-04-1734

OAAI